Physician profile
Brian E Walkowski
NPI 1154767986
$11,132.01
in general payments reported to CMS, 2019-2025
26 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.58 · 2020: $2,041 · 2021: $4,520 · 2022: $540 · 2023: $3,092 · 2024: $513 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,133 · Travel and Lodging: $1,840 · Entertainment: $25.72 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,133.37 |
| Travel and Lodging | $1,840.34 |
| Entertainment | $25.72 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,217.58 | 2020-2024 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $1,485.03 | 2021-2024 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial |
| Ethicon US, LLC | $449.57 | 2021-2025 | Stratafix, Vistaseal, Surgiflo Hemostatic Matrix |
| Conmed Corporation | $155.01 | 2022 | |
| Teleflex LLC | $120.32 | 2024-2025 | Titan Sgs Bailout Chuck, Titan Sgs |
| Medtronic, INC. | $111.81 | 2023-2024 | Endurant Iis, Ellipsys Vascular Access System |
| Cumberland Pharmaceuticals, INC. | $89.04 | 2022 | |
| Smith+Nephew, INC. | $63.79 | 2024-2025 | Stravix, Renasys Touch |
| Abbott Laboratories | $63.38 | 2022-2023 | Proclaim |
| Hologic Sales and Service, LLC | $38.21 | 2025 | Magtrace, Sentimag |
| Inari Medical, INC. | $36.10 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $33.66 | 2022-2023 | Xarelto |
| Novo Nordisk INC | $30.32 | 2019-2025 | Wegovy |
| Kub Technologies INC. | $25.72 | 2023 | Mozart |
| Lilly USA, LLC | $24.10 | 2023 | Zepbound |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Distalmotion US | $23.38 | 2025 | Dexter L6 Robot |
| Pacira Pharmaceuticals Incorporated | $21.57 | 2023 | Iovera, Zilretta, Exparel |
| Braintree Laboratories, INC. | $19.76 | 2022 | |
| Innocoll Pharmaceuticals Limited | $18.52 | 2022 | |
| Baxter Healthcare | $18.16 | 2021 | |
| Karl Storz Endoscopy-America | $17.02 | 2025 | |
| Silk Road Medical, INC. | $15.54 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Lemaitre Vascular, INC. | $15.29 | 2022 | |
| Currax Pharmaceuticals LLC | $14.83 | 2023 | Onzetra Xsail, Contrave |
| Abbvie INC. | $12.50 | 2022 | |
| Ferring Pharmaceuticals INC. | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Walkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.